ARCHIVES

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

This article is from The Cancer Letter archive.

Vol. 37 No. 46 | December 16, 2011

Download PDF Visit The Full Archive

Related Articles

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

Clearinghouse Agrees: Three Dyes, Hair Color Agent Are Carcinogens; Risk To Humans – Brown

May 5, 1978

NIH Acknowledges Role Of Pasteur Virus In AIDS Test, Gives France More Royalties

July 15, 1994

Adjuvant Radiation Treatment Shows Improved Survival In Elderly, Early-Stage Patients

November 30, 2012

Hammer, ACS Agree n Procedures for Award Of Facilities Survey Contract

March 30, 1984

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003